ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $10,255,000 | +576.9% | 221,330 | +256.1% | 0.00% | +300.0% |
Q1 2019 | $1,515,000 | +225.1% | 62,157 | +90.1% | 0.00% | – |
Q4 2018 | $466,000 | +166.3% | 32,704 | +183.6% | 0.00% | – |
Q3 2018 | $175,000 | +2.3% | 11,530 | +13.7% | 0.00% | – |
Q2 2018 | $171,000 | -19.0% | 10,138 | -21.3% | 0.00% | – |
Q1 2018 | $211,000 | +379.5% | 12,874 | +266.7% | 0.00% | – |
Q4 2017 | $44,000 | -80.8% | 3,511 | -81.1% | 0.00% | – |
Q3 2017 | $229,000 | +2762.5% | 18,620 | +1889.3% | 0.00% | – |
Q2 2017 | $8,000 | -87.7% | 936 | -87.1% | 0.00% | – |
Q1 2017 | $65,000 | -83.4% | 7,264 | -83.7% | 0.00% | – |
Q4 2016 | $392,000 | +1407.7% | 44,579 | +1070.1% | 0.00% | – |
Q3 2016 | $26,000 | -35.0% | 3,810 | -66.3% | 0.00% | – |
Q2 2016 | $40,000 | -11.1% | 11,310 | -27.5% | 0.00% | – |
Q1 2016 | $45,000 | -70.2% | 15,590 | -56.1% | 0.00% | – |
Q4 2015 | $151,000 | -30.7% | 35,535 | -25.8% | 0.00% | – |
Q3 2015 | $218,000 | +194.6% | 47,875 | +363.9% | 0.00% | – |
Q2 2015 | $74,000 | 0.0% | 10,321 | -36.4% | 0.00% | – |
Q2 2014 | $74,000 | +362.5% | 16,225 | +377.2% | 0.00% | – |
Q1 2014 | $16,000 | -87.4% | 3,400 | -86.6% | 0.00% | – |
Q4 2013 | $127,000 | -21.1% | 25,336 | -2.4% | 0.00% | – |
Q3 2013 | $161,000 | +66.0% | 25,960 | +22.1% | 0.00% | – |
Q2 2013 | $97,000 | – | 21,254 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
FBR & Co. | 113,500 | $706,000 | 1.07% |
Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |